Linsitinib | Inhibits IGF-1R kinase and InsR kinase

CAS:
867160-71-2
Catalog Number:
10-4814
Activity:
Inhibits IGF-1R kinase and InsR kinase
Chemical Name:
3-[8-Amino-1-(2-phenyl-7-quinolyl)imidazo[1,5-a]pyrazin-3-yl]-1-methyl-cyclobutanol
Alternate Names:
OSI-906
Molecular Weight:
421.49
Molecular Formula:
C26H23N5O
Solubility:
Soluble in DMSO (up to 30 mg/ml)
Physical Properties:
Yellow solid
Purity:
98% by HPLC
NMR (Conforms)
Storage Temperature:
-20°C
Stability:
Stable for 1 year from date of purchase as supplied. Solutions in DMSO may be stored at -20°C for up to 2 months.
Shipping Code:
RT

Available Options

Size :PriceQuantity 
10 mg$60.00
50 mg$195.00
This product is also available in the following library:

Linsitinib (867160-71-2) is a potent and selective dual inhibitor of insulin-like growth factor 1 (IGF-1R) kinase and insulin receptor (InsR) kinase (IC50’s = 35 and 75 nM respectively).1  It has been investigated as a chemotherapeutic in combination with other drugs for various cancers.2-6

References/Citations:

1) Mulvihill et al. (2009), Discovery of OSI-906: a selective and orally efficacious inhibitor of the IGF-1 receptor and insulin receptor; Future Med. Chem. 1 1153
2) Bendell et al. (2015), A phase Ib study of linsitinib (OSI-906), a dual inhibitor of IGF-1R and IR tyrosine kinase, in combination with everolimus as treatment for patients with refractory metastatic colorectal cancer; Invest. New Drugs 33 187
3) Pivonello et al. (2016), The dual targeting of insulin and insulin-like growth factor 1 receptor enhances the mTOR inhibitor-mediated antitumor efficacy in hepatocellular carcinoma ; Oncotarget 7 9718
4) Lee et al. (2016), Inhibition of IGF1R signaling abrogates resistance to afatinib (BIBW2992) in EGFR T790M mutant lung cancer cells; Mol. Carcinog. 55 991
5) Macaulay et al. (2016), Phase I Dose-Escalation Study of Linsitinib (OSI-906) and Erlotinib in Patients with Advanced Solid Tumors; Clin. Cancer Res. 22 2897
6) De Lint et al. (2016), Sensitizing Triple-Negative Breast Cancer to PI3K Inhibition by Cotargeting IGF1R; Mol. Cancer Ther. 15 1545

CAS:
867160-71-2
Catalog Number:
10-4814
Activity:
Inhibits IGF-1R kinase and InsR kinase
Chemical Name:
3-[8-Amino-1-(2-phenyl-7-quinolyl)imidazo[1,5-a]pyrazin-3-yl]-1-methyl-cyclobutanol
Alternate Names:
OSI-906
Molecular Weight:
421.49
Molecular Formula:
C26H23N5O
Solubility:
Soluble in DMSO (up to 30 mg/ml)
Physical Properties:
Yellow solid
Purity:
98% by HPLC
NMR (Conforms)
Storage Temperature:
-20°C
Stability:
Stable for 1 year from date of purchase as supplied. Solutions in DMSO may be stored at -20°C for up to 2 months.
Shipping Code:
RT

Safety Data Sheet:

N/A

Product Data Sheet:

Materials provided by Focus Biomolecules are for laboratory research use only and are not intended for human or veterinary applications. Please note that we do not sell to individuals and that all orders placed by non-research organizations will incur a $20 restocking/refund fee

20% OFF

For Postdoc
Customers!